HRS Investment Holdings’s Edwards Lifesciences EW Stock Holding History

HRS Investment Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-45,000	Closed	-$2.3M	–	19
2018 Q4	$2.3M	Buy	45,000 +15,000	+50%	+$759K	1.28%	15
2018 Q3	$1.74M	Buy	30,000 +7,500	+33%	+$367K	0.8%	41
2018 Q2	$1.09M	Sell	22,500 -7,500	-25%	-$350K	0.55%	54
2018 Q1	$1.4M	Hold	30,000	–	–	0.68%	45
2017 Q4	$1.13M	Hold	30,000	–	–	0.59%	57
2017 Q3	$1.09M	Hold	30,000	–	–	0.66%	53
2017 Q2	$1.18M	Sell	30,000 -30,000	-50%	-$1.1M	0.77%	50
2017 Q1	$1.88M	Buy	60,000 +7,500	+14%	+$235K	1.35%	24
2016 Q4	$1.64M	Buy	+52,500	New	+$1.7M	1.32%	29

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HRS Investment Holdings's EW Position: Q1 2019 in Review

HRS Investment Holdings sold out of Edwards Lifesciences (EW) in Q1 2019, closing a stake of 45,000 shares — an estimated $2.3M sold.

HRS Investment Holdings first reported a position in EW in Q4 2016 and held it in 9 quarters. The position peaked at $2.3M in Q4 2018. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

HRS Investment Holdings reported no remaining Edwards Lifesciences position as of Q1 2019 after selling out during the quarter.
HRS Investment Holdings sold 45,000 Edwards Lifesciences shares in Q1 2019, an estimated $2.3M.
HRS Investment Holdings first reported a position in Edwards Lifesciences in Q4 2016 and held it in 9 quarters.
HRS Investment Holdings's Edwards Lifesciences position peaked at $2.3M in Q4 2018.
922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on HRS Investment Holdings's 13F filing for Q1 2019, filed 15 May 2019.